Stem Cell Therapy for Psoriasis
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Advanced MSC treatments modulating overactive T-cell response, reducing inflammatory cytokines, and promoting lasting skin tissue repair for psoriasis and psoriatic arthritis.
Evidence at a glance — Psoriasis
A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.
- Human studies available?
- Limited
- Randomised trials?
- Isolated small trials and case reports
- Main outcomes studied
- PASI score
- Skin biopsy findings
- Relapse interval
- Safety
- Long-term evidence
- Very limited
- Regulatory approval for this indication
- United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
- European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
- United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
- Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
- Role at our centre
- Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it
What kind of evidence exists
- Mechanism (laboratory): Documented
- Animal / preclinical: Documented
- Early human (phase 1/2, uncontrolled): Documented
- Controlled human (randomised or sham-controlled): Not established
- Regulatory approval: Not established
Sources
- Systematic reviews and meta-analyses — Psoriasis — PubMed
- Randomised controlled trials — Psoriasis — PubMed
- Registered MSC trials — Psoriasis — ClinicalTrials.gov
- FDA — Consumer alert on regenerative medicine therapies — U.S. Food and Drug Administration, 2024
- Advanced therapy medicinal products: overview — European Medicines Agency, 2025
- ISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research, 2021
- ISSCR Patient Handbook on Stem Cell Therapies — International Society for Stem Cell Research, 2020
Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.
This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.
What is Psoriasis?
Psoriasis is a chronic autoimmune condition affecting over 125 million people worldwide. It causes rapid skin cell turnover, resulting in thick, red, scaly patches (plaques) that can be itchy, painful, and socially distressing. The condition is driven by an overactive immune response, particularly T-cell dysfunction.
Conventional treatments include topical steroids, phototherapy, and biologic drugs that suppress specific immune pathways. However, these often require lifelong use and may lose effectiveness over time. MSC therapy offers a fundamentally different approach by rebalancing the immune system rather than merely suppressing it.
At StemCell Longevita, our immunomodulatory MSC protocols address the root autoimmune dysfunction driving psoriasis, offering the potential for lasting improvement without the ongoing immunosuppression required by conventional biologics.
Ideal Candidates
- Patients with moderate to severe plaque psoriasis
- Those with psoriatic arthritis affecting joints
- Patients who have not responded well to biologics or conventional treatments
- Individuals seeking alternatives to long-term immunosuppressive therapy
- Patients experiencing significant quality-of-life impact from psoriasis
How Stem Cell Therapy Helps Psoriasis
Immune Rebalancing
MSCs modulate the overactive T-cell response that drives psoriasis, promoting regulatory T-cell generation for lasting immune balance.
Plaque Reduction
Anti-inflammatory effects lead to significant reduction in plaque size, thickness, and redness, with many patients achieving near-complete clearance.
Joint Protection
For psoriatic arthritis, MSCs provide both joint repair and immune modulation, addressing both skin and joint manifestations simultaneously.
Lasting Results
Unlike biologics requiring ongoing treatment, MSC therapy can provide extended periods of improvement from one or two treatment courses.
Treatment Process
Your step-by-step treatment journey at StemCell Longevita
Dermatological Assessment
PASI scoring, evaluation of affected body surface area, joint assessment for psoriatic arthritis, and immune biomarker analysis.
Protocol Design
Personalized treatment plan based on psoriasis type, severity, affected areas, and presence of psoriatic arthritis.
MSC Preparation
Wharton's jelly MSCs with optimal immunomodulatory properties prepared in our GMP-certified laboratory.
IV Infusion
Intravenous MSC delivery for systemic immune modulation, targeting the autoimmune dysfunction at its source.
Response Monitoring
PASI scoring at 1, 3, and 6 months post-treatment to track skin clearance and plan any follow-up sessions.
Patient Experiences
Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul
"My rheumatologist was surprised by the improvement. I can hold my grandchildren's hands again without wincing — that means everything to me."
"Lupus controlled my life for a decade. After treatment in Istanbul, I travelled to three countries in one month — something unimaginable a year ago."
Frequently Asked Questions
All Regenerative Medicine Applications
Explore our comprehensive range of regenerative medicine applications for various conditions. Click any option to learn more.
Related Articles
Explore our in-depth research articles and guides on related treatments and therapies.
Regenerative Approaches for Autoimmune Conditions: Research & Outcomes
Research on how mesenchymal stem cell approaches modulate the immune system to address autoimmune conditions including lupus, rheumatoid arthritis, and Crohn's disease.
Read ArticleUnderstanding Regenerative Medicine: A Complete Guide
A comprehensive overview of stem cell therapy, including types of stem cells, care processes, safety considerations, and what patients can expect during their wellness journey.
Read ArticleExosome Therapy: The Next Frontier in Regenerative Medicine
Learn about exosome therapy and how these powerful cellular messengers are being studied to support tissue repair, reduce inflammation, and support overall wellness processes.
Read ArticleRelated clinical questions
Where this page sits in the wider picture.